Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Margaret Mueller

Urogynecology and Reconstructive Pelvic Surgery Chicago, IL Medical Doctor

NPI 1346570405 CMS profile 1198769

676 N Saint Clair St, Suite 950, Chicago, IL 60611

Open in the dashboard

General payments

$25,689

69 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$4,128 paid to institutions, not to them · program year 2020

Through program year 2025, Margaret Mueller of Chicago, IL is reported in the CMS Open Payments database as having received $25,689 across 69 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $4,128 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Urogynecology and Reconstructive Pelvic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,913 16
2024 General $5,154 10
2023 General $1,773 10
2022 General $404 7
2021 General $7,124 22
2019 General $321 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Margaret Mueller
  • Urogynecology and Reconstructive Pelvic Surgery median
  • Middle half of Urogynecology and Reconstructive Pelvic Surgery
  • National median

In program year 2025, general payments to Margaret Mueller were reported at $10,913. Among 802 Urogynecology and Reconstructive Pelvic Surgery profiles paid that year, the median was $412 and the middle half received between $133 and $1,300.

Show as a table
Year Margaret Mueller Urogynecology and Reconstructive Pelvic Surgery median Middle half National median
2019 $321 $358 $132–$1,270 $163
2020 $0 $198 $86–$642 $114
2021 $7,124 $361 $118–$1,182 $132
2022 $404 $410 $128–$1,175 $149
2023 $1,773 $434 $152–$1,344 $160
2024 $5,154 $494 $193–$1,331 $164
2025 $10,913 $412 $133–$1,300 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $8,931 23 payments
  2. GlaxoSmithKline, LLC. $8,650 4 payments
  3. Boston Scientific Corporation $2,601 17 payments
  4. Caldera Medical, Inc $2,307 3 payments
  5. Axonics Modulation Technologies, Inc. $1,627 7 payments
  6. Bluewind Medical $758 4 payments
  7. Coloplast Corp $493 4 payments
  8. Baxter Healthcare $205 3 payments
  9. Medtronic, Inc. $67 3 payments
  10. Applied Medical Resources Corporation $51 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $11,850 7 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,545 3 payments
  3. Education $3,000 1 payment
  4. Food and Beverage $2,712 43 payments
  5. Travel and Lodging $2,582 15 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System Surgery $5,931 22 payments
  2. Da Vinci Surgical System Surgery $3,000 1 payment
  3. Desara $2,307 3 payments
  4. Advantage System $1,926 7 payments
  5. Axonics $1,424 5 payments
  6. REVI $758 4 payments
  7. Altis $276 2 payments
  8. PERCLOT $205 3 payments
  9. SOLYX $190 3 payments
  10. Upsylon $166 2 payments
  11. Other $819 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

131

Median for Obstetrics & Gynecology: 65

Drug cost

$41,518

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

77.1%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gemtesa Vibegron Brand 76 $39,609
Estradiol Generic 30 $1,676
Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst Brand 25 $233

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$55,459

Medicare's payments for the services billed

Medicare patients

129

Average age 74

Services billed

997

129 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Arthritis 54%
Osteoporosis 37%
Depression 29%
Diabetes 24%
Cancer 22%
Ischemic heart disease 21%
Atrial fibrillation 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urogynecology and Reconstructive Pelvic Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record